US 12,214,200 B2
Sensing reference electrode for percutaneous neuromodulation trials
Joseph M. Bocek, Seattle, WA (US); Michael X. Govea, Rancho Santa Margarita, CA (US); and Rosana Esteller, Santa Clarita, CA (US)
Assigned to Boston Scientific Neuromodulation Corporation, Valencia, CA (US)
Filed by Boston Scientific Neuromodulation Corporation, Valencia, CA (US)
Filed on May 10, 2023, as Appl. No. 18/195,690.
Application 18/195,690 is a continuation of application No. 16/895,737, filed on Jun. 8, 2020, granted, now 11,648,399.
Claims priority of provisional application 62/859,430, filed on Jun. 10, 2019.
Prior Publication US 2023/0277848 A1, Sep. 7, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/36 (2006.01); A61N 1/05 (2006.01)
CPC A61N 1/36132 (2013.01) [A61N 1/0502 (2013.01); A61N 1/0551 (2013.01); A61N 1/36017 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method for sensing a signal from a patient, the method comprising:
delivering neurostimulation energy to the patient from an external test device via a percutaneous stimulation lead having a lead proximal end and a lead distal end, the external test device placed externally to the patient, the lead proximal end including a lead connector connected to the external test device, the lead distal end including one or more electrodes placed in the patient; and
sensing the signal from the patient using the external test device via the percutaneous stimulation lead and a percutaneous sensing wire being at least partially separated from the percutaneous stimulation lead and having a wire proximal end and a wire distal end, the wire proximal end including a wire connector connected to the external test device, the wire distal end connected to a sensing reference electrode placed in the patient.